BIO-key International, Inc. received a notice from Nasdaq regarding its failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2026, which serves as an additional basis for delisting. A hearing with the Nasdaq Hearing Panel is scheduled for June 16, 2026, to consider the continued listing status of compliance with the Periodic Report Rule. BIO-key International, Inc. is a provider of biometric authentication and identity management solutions.
